Ingredion Incorporated INGR trades at a sizable discount, while its higher-value specialty portfolio continues to improve. That combination creates a credible value case.
The obstacle is execution. Operational problems at the Argo facility have reduced earnings visibility, and the updated outlook assumes a recovery that still has to be delivered.
Ingredion’s Valuation Builds a Margin of Safety
Ingredion trades at 8.76X forward 12-month earnings, below its five-year median of 11.79X and the food sub-industry multiple of 14.88X. The gap provides a valuation cushion if operations normalize.
The discount is not unexplained. Shares have faced weak momentum, estimate pressure and concern over Argo. Archer-Daniels-Midland Company ADM also reported weaker global starches and sweeteners demand in late 2025, underscoring that Ingredion is managing both company-specific and broader market pressure.
Image Source: Zacks Investment Research
INGR’s Specialty Engine Supports the Bull Case
Texture & Healthful Solutions remains the strongest part of the portfolio. In 2025, segment operating income increased 16% to $405 million, while operating margin expanded more than 200 basis points to 16.9%.
Volume growth continued into the first quarter of 2026, marking an eighth consecutive quarterly increase. Clean-label sales rose at a double-digit rate in Europe, the Middle East and Africa and Asia-Pacific, while the roughly $1 billion solutions portfolio continued to outpace segment growth. International Flavors & Fragrances Inc. IFF, which supplies texturants, sweeteners and customized systems for food and beverage applications, provides another relevant industry reference point for the shift toward formulation-led growth.
Â
Image Source: Zacks Investment Research
Ingredion’s Argo Recovery Keeps Risk Elevated
Argo remains the central risk. Ingredion initially expected $10-$15 million of additional first-quarter costs, but the actual impact reached about $40 million because of maintenance, rework, logistics expenses and lower yields.
Management said downstream production returned to normal levels by quarter-end, but the outlook depends on sustaining reliability and yield. A separate April thermal event also interrupted corn germ processing, adding another recovery task.
Â
Image Source: Zacks Investment Research
INGR’s Earnings Outlook Still Lacks Clarity
Ingredion lowered adjusted earnings guidance to $10.45-$11.15 per share from $11.00-$11.80. It also reduced the adjusted operating-income outlook to flat or down low single digits.
Food & Industrial Ingredients demand remains soft in several markets. Higher energy and logistics costs, Mexican peso pressure and weaker Latin American demand could slow the rebound, particularly if pricing actions do not offset inflation quickly.
Ingredion’s Cash Flow Preserves Flexibility
Liquidity gives Ingredion room to keep investing. At March 31, 2026, cash and short-term investments were $918 million, compared with $1.8 billion of debt.
The company expects $725-$825 million of operating cash flow in 2026 and plans $400-$440 million of capital expenditures. That supports reliability projects, innovation, dividends and repurchases, although the capital program leaves less room for error if earnings weaken further.
INGR’s Signals Favor Patience Over Aggression
The valuation and specialty mix support a constructive long-term view, but the near-term decision rests on evidence that Argo is stabilizing and earnings estimates have stopped falling. Until then, the risk-reward profile favors patience rather than an aggressive entry.
Ingredion currently carries a Zacks Rank #4 (Sell), which points to weaker near-term prospects. Its Value Score of A and VGM Score of B reflect attractive valuation and a reasonably balanced style profile, but the Growth Score of D and Momentum Score of C are less supportive. Clearer operational progress and improving estimate revisions would strengthen the case. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Â
Â
Â
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.